Tong Carl W, Gaffin Robert D, Zawieja David C, Muthuchamy Mariappan
336 Reynolds Medical Building, Cardiovascular Research Institute and Department of Medical Physiology, College of Medicine, Texas A & M University System Health Science Center, College Station, TX 77843-1114, USA.
J Physiol. 2004 Aug 1;558(Pt 3):927-41. doi: 10.1113/jphysiol.2004.062539. Epub 2004 Jun 11.
A normal heart increases its contractile force with increasing heart rate. Although calcium handling and myofibrillar proteins have been implicated in maintaining this positive force-frequency relationship (FFR), the exact mechanisms by which it occurs have not been addressed. In this study, we have developed an analytical method to define the calcium-force loop data, which characterizes the function of the contractile proteins in response to calcium that is independent of the calcium handling proteins. Results demonstrate that increasing the stimulation frequency causes increased force production per unit calcium concentration and decreased frequency-dependent calcium sensitivity during the relaxation phase. We hypothesize that phosphorylation of myosin binding protein-C (MyBP-C) and troponin I (TnI) acts coordinately to change the rates of force generation and relaxation, respectively. To test this hypothesis, we performed simultaneous calcium and force measurements on stimulated intact mouse papillary bundles before and after inhibition of MyBP-C and TnI phosphorylation using the calcium/calmodulin kinase II (CaMK2) inhibitor autocamtide-2 related inhibitory peptide, or the protein kinase A (PKA) inhibitor 14-22 amide. CaMK2 inhibition reduced both MyBP-C and TnI phosphorylation and decreased active force without changing the magnitude of the Ca(2+) transient. This reduced the normalized change in force per change in calcium by 19-39%. Data analyses demonstrated that CaMK2 inhibition changed the myofilament characteristics via a crossbridge feedback mechanism. These results strongly suggest that the phosphorylation of MyBP-C and TnI contributes significantly to the rates of force development and relaxation.
正常心脏会随着心率增加而增强其收缩力。尽管钙处理和肌原纤维蛋白与维持这种正向力-频率关系(FFR)有关,但其发生的确切机制尚未得到阐明。在本研究中,我们开发了一种分析方法来定义钙-力环数据,该数据表征了收缩蛋白响应钙的功能,且独立于钙处理蛋白。结果表明,增加刺激频率会导致单位钙浓度产生的力增加,以及舒张期频率依赖性钙敏感性降低。我们假设肌球蛋白结合蛋白-C(MyBP-C)和肌钙蛋白I(TnI)的磷酸化分别协同作用,以改变力产生和舒张的速率。为了验证这一假设,我们使用钙/钙调蛋白激酶II(CaMK2)抑制剂自磷酸化钙调蛋白-2相关抑制肽或蛋白激酶A(PKA)抑制剂14-22酰胺,在抑制MyBP-C和TnI磷酸化前后,对受刺激的完整小鼠乳头肌束进行了同步钙和力测量。CaMK2抑制降低了MyBP-C和TnI的磷酸化,并降低了主动力,而不改变[Ca(2+)]i瞬变的幅度。这使钙每变化时力的归一化变化降低了19-39%。数据分析表明,CaMK2抑制通过横桥反馈机制改变了肌丝特性。这些结果强烈表明,MyBP-C和TnI的磷酸化对力发展和舒张的速率有显著贡献。